imatinib mesylate has been researched along with Vertigo in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bauer, H; Frickhofen, N; Hochhaus, A; Jung, B; Märker-Hermann, E; Reiter, A; Walz, C | 1 |
1 other study(ies) available for imatinib mesylate and Vertigo
Article | Year |
---|---|
Complete molecular remission of chronic eosinophilic leukemia complicated by CNS disease after targeted therapy with imatinib.
Topics: Adult; Antineoplastic Agents; Arm; Azathioprine; Benzamides; Brain; Cerebellar Ataxia; Cerebellar Cortex; Enzyme Inhibitors; Headache; Humans; Hypereosinophilic Syndrome; Imatinib Mesylate; Immunosuppressive Agents; Leukemic Infiltration; Magnetic Resonance Imaging; Male; Memory Disorders; mRNA Cleavage and Polyadenylation Factors; Oncogene Proteins, Fusion; Paresis; Parietal Lobe; Piperazines; Polyarteritis Nodosa; Prednisone; Pyrimidines; Receptor, Platelet-Derived Growth Factor alpha; Remission Induction; Vertigo | 2004 |